MedTrace Logo

Medication Review in Patients on Anti-parkinson Therapy

NCT00443768 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2013-02-04

No results posted yet for this study

Summary

To identify patients within the community taking anti-parkinson medications in whom the diagnosis of Parkinson's disease is incorrect and to supervise and clinically monitor the withdrawal of anti-parkinson medications in this patient group

Conditions

Sponsors & Collaborators

  • South Glasgow University Hospitals NHS Trust

    lead OTHER

Principal Investigators

  • Donald Grosset, MD · Dept of Neurology, INS, Southern General Hospital

  • Edward Newman, MRCP · Dept of Neurology, INS, Southern General Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00443768 on ClinicalTrials.gov